Saturday, July 13, 2024

Medical Technology Revisions Announced by Korea Institute for 2024

Similar articles

Medical technology revisions have been announced by the Korea Institute of Health and Medical Research, led by President Lee Jae-tae, to the notice of new technologies deemed safe and effective during the 3rd Ministry of Health and Welfare New Medical Technology Evaluation Committee meeting in 2024. Introduced in 2007, the New Medical Technology Evaluation System aims to assess the safety and clinical effectiveness of new medical technologies, including treatments and testing methods. The system is designed to prevent the indiscriminate use of unverified medical technologies and to protect public health.

For patients with postpartum hemorrhage, this medical technology involves inserting a silicone loop with a hole through the vagina, sealing the entrance to the uterus, and inducing contraction of the uterine wall by applying negative pressure (up to 90 mmHg). The procedure showed no deaths or uterine ruptures, a short time to hemostasis, high treatment success rates, and lower rates of massive blood transfusion, blood loss, and additional treatments compared to existing technology (intrauterine balloon catheter compression hemostasis). However, caution is advised for patients with postpartum hemorrhage who are less than 34 weeks pregnant (early delivery).

New Medical Technology Enhances Treatment for Pancreatitis and Colon Cancer Patients

For patients with severe acute pancreatitis who do not improve after drainage surgery, this technique removes the necrotic part of the pancreas using an endoscope inserted through a drainage tube, facilitating the drainage of accumulated body fluid. Recommended in related textbooks and guidelines, this technique showed lower death and procedure-related complications than open surgery and produced similar results to minimally invasive procedures, making it a safe and effective method.

For patients with colon cancer requiring surgery, this medical technology evaluates perfusion through images of the fluorescent contrast agent indocyanine green injected intravenously and irradiated with a near-infrared light source during surgery. Indocyanine green is a non-toxic, stable dye that is easily excreted from the body. This technique is already used clinically for checking blood circulation and is recommended in guidelines for perfusion evaluation during colon cancer surgery, reducing anastomotic leakage and related complications.

For colon cancer patients requiring surgery, this medical technology assists lymph node dissection by injecting indocyanine green around the cancer before or during surgery and identifying lymph nodes through fluorescence images irradiated by a near-infrared light source. The injection is safe with no reported complications or adverse reactions. Compared to traditional methods, this technique significantly increased the number of lymph nodes obtained and showed similar or lower post-operative complications and bleeding, making it a valid technique.

Medical Technology

New Technique for Knee Osteoarthritis Shows Promise in Improving Joint Function and Pain Relief

For patients with knee osteoarthritis (Kellgren-Lawrence grade 2-3), this technique improves knee joint function and relieves pain by injecting autologous fat-derived stromal vascular fraction extracted from the patient’s abdomen or buttocks into the knee joint cavity. The procedure showed no serious complications, only minor ones related to the procedure. Compared to existing technologies, such as intra-articular injections using hyaluronic acid, it demonstrated superior or similar levels of functional improvement and pain relief, making it an effective medical technology.

These evaluations highlight significant advancements in medical technologies, aiming to improve patient outcomes through safer and more effective treatments. The revised notice and the continuous efforts of the Korea Institute of Health and Medical Research ensure that new medical technologies undergo rigorous assessment to meet safety and efficacy standards. This system protects public health by preventing the use of unverified medical technologies and promoting the adoption of proven beneficial treatments.

The updated notice on the evaluation of new medical technology by the Korea Institute of Health and Medical Research emphasizes the importance of rigorous assessment in ensuring the safety and efficacy of medical practices. The technologies reviewed, including intrauterine negative pressure hemostasis, endoscopic pancreatic necrosis removal, and near-infrared indocyanine green techniques, demonstrate significant potential in improving patient care and outcomes. The commitment to ongoing evaluation and improvement of medical technology is crucial for advancing healthcare and protecting public health.


You can follow our news on our Telegram and LinkedIn accounts.

Resource: The Korea Institute of Health and Medical Research, June 28, 2024

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article